Proof of Concept Study of AX-158 in Patients With Mild to Moderate Plaque Psoriasis
Clinical trial NCT05725057 · COMPLETED
Trial details
- NCT number
- NCT05725057
- Sponsor
- Artax Biopharma Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2024-09-04
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.